Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

SANGSTAT MEDICAL CORP Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2003 8-K Quarterly results
07/28/2003 8-K Other events, Financial statements and exhibits, Regulation FD Disclosure
Docs: "SANGSTAT REPORTS RECORD REVENUES OF $33.4 MILLION IN Q2 2003 AND EARNINGS PER SHARE OF $0.07"
04/28/2003 8-K Other events, Financial statements and exhibits, Regulation FD Disclosure
Docs: "SANGSTAT ANNOUNCES Q1 2003 EARNINGS PER SHARE OF $0.07 ON REVENUES OF $29.5 MILLION"
11/15/2002 8-K Other events, Financial statements and exhibits
Docs: "SANGSTAT ANNOUNCES COLLABORATION WITH THP TO DEVELOP"
10/21/2002 8-K Other events, Financial statements and exhibits
Docs: "Item 5. Other Events."
07/15/2002 8-K Other events, Financial statements and exhibits
Docs: "CORINNE H. LYLE JOINS SANGSTAT BOARD OF DIRECTORS"
06/10/2002 8-K Other events, Financial statements and exhibits
Docs: "Certificate of Amendment of the Certificate of Incorporation, filed with the Delaware Secretary of State on June 6, 2002"
05/22/2002 8-K Other events
Docs: "HOLLINGS C. RENTON JOINS SANGSTAT BOARD OF DIRECTORS"
02/05/2002 8-K Other events, Financial statements and exhibits
Docs: "Purchase Agreement, by and among SangStat Medical Corporation, Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities Inc., Thomas Weisel Partners LLC and Wells Fargo Securities, LLC",
"Opinion of Skadden, Arps, Slate, Meagher & Flom LLP"
10/22/2001 8-K Other events
10/09/2001 8-K Other events, Financial statements and exhibits
Docs: "First Amendment to Rights Agreement, by and among SangStat Medical Corporation, Fleet National Bank (f/k/a The First National Bank of Boston) and Equiserve Trust Company, N.A"
09/27/2001 8-K Resignations of registrant's directors
07/13/2001 8-K Other events, Financial statements and exhibits
Docs: "EXHIBIT",
"EXHIBIT"
07/10/2001 8-K Other events, Financial statements and exhibits
Docs: "NICHOLAS J. SIMON III JOINS SANGSTAT'S BOARD OF DIRECTORS Fremont, Calif.- July 9, 2001 - SangStat announced today that Nicholas J. Simon III has been named to its Board of Directors. Mr. Simon is Founder and Chief Executive Officer of Collabra Pharma, a pharmaceutical development company, and has over 20 years of experience in the Biotechnology and Pharmaceutical industries. "We are very fortunate to have someone with Mr. Simon's extensive experience in the biotechnology and pharmaceutical industries join our board," said Jean-Jacques Bienaimé, SangStat's Chairman, President and CEO. "Nick's proven track record and many successes in business development will be a helpful and welcome addition to our board." Prior to Collabra Pharma, Mr. Simon was at Genentech, Inc from 1989 to 2000,..."
06/21/2001 8-K Other events, Financial statements and exhibits
Docs: "Securities Purchase Agreement between the Company and Narragansett I. LP, Narragansett Offshore, Ltd., Royal Bank of Canada, S.A.C. Capital Associates, LLC, and Société Générale",
"Registration Rights Agreement between the Company and Narragansett I. LP, Narragansett Offshore, Ltd., Royal Bank of Canada, S.A.C. Capital Associates, LLC, and Société Générale",
"SANGSTAT COMPLETES $15 MILLION PRIVATE PLACEMENT"
05/04/2001 8-K Other events, Financial statements and exhibits
Docs: "EXHIBIT"
05/02/2001 8-K Other events, Financial statements and exhibits
Docs: "EXHIBIT"
04/23/2001 8-K Other events, Financial statements and exhibits
04/05/2001 8-K Other events, Financial statements and exhibits
Docs: "EXHIBIT"
02/27/2001 8-K Other events, Financial statements and exhibits
Docs: "SANGSTAT REPORTS FOURTH-QUARTER AND 2000 EARNINGS"
01/08/2001 8-K Other events, Financial statements and exhibits
Docs: "Securities Purchase Agreement between the Company and Narragansett I. LP, Narragansett Offshore, Ltd., Royal Bank of Canada, and SDS Capital Partners, LLC",
"Registration Rights Agreement between the Company and Narragansett I. LP, Narragansett Offshore, Ltd., Royal Bank of Canada, and SDS Capital Partners, LLC",
"SANGSTAT COMPLETES $12.5 MILLION PRIVATE PLACEMENT Fremont, Calif.- January 8, 2001 - SangStat announced today that it has completed a private placement of approximately 1.3 million shares of common stock for aggregate proceeds of approximately $12.5 million with a group of institutional investors, including some who were already stockholders of SangStat. Shares were purchased at a discount to the closing market price at the date the agreements were signed. The transaction occurred in two tranches, the first of which closed December 29, 2000, the second of which closed January 5, 2001. SangStat did not pay any investment banking fees and did not issue any warrants with respect to this private placement. SangStat intends to use the proceeds from the sale of its common stock for working capi..."
10/17/2000 8-K Other events, Financial statements and exhibits
Docs: "Nasdaq: SANG)",
"Nasdaq: SANG)"
10/06/2000 8-K Other events, Financial statements and exhibits
Docs: "Nasdaq: SANG)"
08/30/2000 8-K Other events, Financial statements and exhibits
Docs: "Certificate of Amendment of the Certification of Incorporation"
08/02/2000 8-K Other events, Financial statements and exhibits
Docs: "PRESS RELEASE DATED 7/27/2000"
07/21/2000 8-K Other events
07/14/2000 8-K Other events, Financial statements and exhibits
Docs: "PRESS RELEASE 99.1",
"PRESS RELEASE 99.2"
05/17/2000 8-K Other events, Financial statements and exhibits
Docs: "(510) 789-4331"
02/28/2000 8-K Other events, Financial statements and exhibits
Docs: "SANGSTAT COMPLETES $15 MILLION PRIVATE PLACEMENT"
01/12/1999 8-K Other events, Financial statements and exhibits
12/14/1998 8-K/A Financial statements and exhibits
10/15/1998 8-K Acquisition or disposition of assets

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy